ImmunoGen Inc (NASDAQ:IMGN)

14.01
Delayed Data
As of Jul 02
 -0.26 / -1.82%
Today’s Change
5.34
Today|||52-Week Range
15.88
+129.67%
Year-to-Date

Today’s Trading

Previous close14.27
Today’s open14.31
Day’s range14.00 - 14.31
Volume902,202
Average volume (3 months)2,018,954
Market cap$1.2B
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+4.60%
Earnings growth (this year)+17.82%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+68.55%
P/E ratioNM
Price/Sales16.91
Price/Book15.90

Competitors

 Today’s
change
Today’s
% change
ADAPAdaptimmune Therapeu...+0.43+2.45%
FMIFoundation Medicine ...-1.00-2.95%
RTRXRetrophin Inc-0.64-1.97%
ATRAAtara Biotherapeutic...+0.17+0.38%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateJuly 31, 2015
EPS forecast (this quarter)-$0.34
Annual revenue (last year)$59.9M
Annual profit (last year)-$71.4M
Net profit margin-119.15%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Daniel M. Junius
Chief Financial Officer &
Executive Vice President
David B. Johnston
Corporate headquarters
Waltham, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers